![Flavio Finotello](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Flavio Finotello
Directeur Général chez PZ CORMAY S.A.
Postes actifs de Flavio Finotello
Sociétés | Poste | Début | Fin |
---|---|---|---|
PZ CORMAY S.A. | Directeur Général | 01/12/2023 | - |
Corporate Officer/Principal | 01/09/2017 | - | |
ORPHÉE SA | Président | 01/01/2022 | - |
Historique de carrière de Flavio Finotello
Formation de Flavio Finotello
University of Melbourne | Graduate Degree |
Statistiques
Internationale
Pologne | 2 |
Australie | 2 |
Suisse | 2 |
Opérationnelle
Chief Executive Officer | 1 |
Corporate Officer/Principal | 1 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
PZ CORMAY S.A. | Health Technology |
Entreprise privées | 1 |
---|---|
Orphée SA
![]() Orphée SA Medical SpecialtiesHealth Technology Orphée SA engages in the development and marketing of tools for hematology diagnostic market to small and medium sized laboratories. Its products include Mythic Lyte, Mythic 18 Vet, Mythic 18, Mythic 22 AL, Mythic 22 OT, and Mythic TS. The company was founded in 2002 and is headquartered in Geneva, Switzerland. | Health Technology |
- Bourse
- Insiders
- Flavio Finotello
- Expérience